Raffles Medial Group (RMG)

For the full year, the company posted revenue of $706.9 million, down 14.1% from the $822.9 million recorded in FY2022.

RHB has kept its "buy" call and target price at $1.75.

Raffles Medical is Maybank’s preferred pick in the healthcare sector.

This is the fifth consecutive month that the alpha picks portfolio has beaten the STI.

See the analysts' recommendations and target prices here.

CGS-CIMB Research upgrades recommendation on Raffles Medical to “add” from “hold” with a $1.22 target price.

See the analysts' recommendations and target prices here.

Following a share price correction, Maybank Kim Eng Research analyst Lai Gene Lih has upgraded Raffles Medical Group to “buy”.

Raffles Medical is looking to remain profitable in 2020, barring unforeseen circumstances like the prolongation of the novel coronavirus outbreak

SINGAPORE (20 Dec) : Eight in 10 medical practitioners say Singapore’s healthcare system should focus more on disease prevention as Singaporeans live longer and are more likely to contract a chronic illness at an earlier age. Moreover, nearly half or 49